Jonathan Schur is a partner in Goodwin’s Life Sciences group. Mr. Schur advises pharmaceutical and medical device companies in structuring collaborations, mergers, acquisitions and divestitures, and advancing products from discovery until commercialization. He has significant experience in cross-border transactions and is known for his ability to bring parties of transactions together, effectively bridging legal and cultural differences, in particular between European and U.S. companies. He also works with clients to arrange venture and later-stage financing, as well as representing them pre-IPO and at the IPO stage.

Mr. Schur counsels companies with activities that cross the Atlantic or Pacific on legal and management issues that need to be addressed to ensure efficient operations and achieve regulatory compliance. This includes the regulatory aspects of product and pricing authorizations, clinical trials, agreements with hospitals and physicians, privacy and marketing practices in the life sciences sector.

Listed in Chambers Europe 2012 for Pharma-Life Sciences Corporate in France, “dual U.S. and French qualified Jonathan Schur has a strong corporate and regulatory background. He regularly advises pharma and medical device clients on M&A and joint ventures.” In addition, Mr. Schur is listed by The Legal 500 (U.S.) for life sciences, where he is cited as being “highly skilled and committed.” He is also recommended by Practical Law Company’s “Which Lawyer?” guide for both regulatory and corporate matters.

Prior to joining Goodwin in 2018, Mr. Schur was a partner and former co-managing partner of the Paris office at Dechert LLP. He is fluent in French and English.

Areas of Practice
TÄTIGKEITSFELDER
Domaines D’Expertise
业务范围

Experience

ERFAHRUNG

EXPÉRIENCE

工作经历

Significant representations include:

  • A Copenhagen-based biopharmaceutical company in negotiation of an exclusive global license and collaboration agreement with one of the world’s leading pharmaceutical companies.*
  • A Japanese pharmaceutical company in connection with a European commercialization agreement for an oncology product.*
  • A Copenhagen-based biopharmaceutical company in negotiation of an exclusive development and license agreement with a major European pharmaceutical company.*
  • A French biopharmaceutical company in connection with a distribution agreement with an American company.*
  • A Copenhagen-based biopharmaceutical company in its IPO, one of the largest European IPOs in the life sciences sector in several years.*
  • A U.S.-based medical products manufacturer in its acquisition of the drug delivery device business assets of a French company.*
  • A Copenhagen-based biopharmaceutical company in a drug discovery agreement with an Australian/American biotechnology company.*
  • A Japanese pharmaceutical company in connection with an ICC arbitration concerning a sale of a marketing authorization.*
  • A Copenhagen-based biopharmaceutical company in a licensing agreement for a late stage product with one of the world’s leading pharmaceutical companies.*

* Denotes experience prior to joining Goodwin.

Professional Activities

Mr. Schur is a former trustee, The American Library in Paris, Inc.; former president, Harvard Law School Association of France, and former administrative director, Union Internationale des Avocats.

In The News

MELDUNGEN

ACTUALITÉS

相关新闻

Credentials

WERDEGANG

RÉFÉRENCES

专业资格

Education

J.D., 1978
Harvard Law School
cum laude
A.B., 1975
Harvard College
cum laude

Admissions

Bar

New York
Paris
Get In Touch
German Translation
NOUS CONTACTER
联系我们
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.
Unsere Kunden verlassen sich auf uns für erstklassige Beratungsdienste, beraten über komplexe Transaktionsarbeiten und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Industrie, verwenden wir eine kooperative, interdisziplinäre Ansatz zur Lösung unserer Kunden am schwierigsten Fragen. Um mehr zu erfahren, kontaktieren Sie uns bitte.

Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.

客户信赖我们世界一流的咨询服务,希望获得针对复杂事务性工作与高风险诉讼的建议。我们通过协作式、跨领域的工作方法来解决客户最棘手的问题,涵盖金融、生命科学、私募股权、不动产和技术等多个行业。如需更多信息,请与我们联系。

Search Other Lawyers
ANWALTSSUCHE
Recherche par Pratique
搜寻其他律师